Black Bird Biotech (Black Bird Biotech) Interest Expense : $-0.52 Mil (TTM As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Black Bird Biotech Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Black Bird Biotech's interest expense for the three months ended in Sep. 2023 was $ -0.12 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.52 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Black Bird Biotech's Operating Income for the three months ended in Sep. 2023 was $ -0.01 Mil. Black Bird Biotech's Interest Expense for the three months ended in Sep. 2023 was $ -0.12 Mil. Black Bird Biotech did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Black Bird Biotech Interest Expense Historical Data

The historical data trend for Black Bird Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Black Bird Biotech Interest Expense Chart

Black Bird Biotech Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.04

-0.01

-0.29

-0.37

Black Bird Biotech Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Interest Expense	Get a 7-Day Free Trial															-0.05	-0.12	-0.18	-0.10	-0.12

Black Bird Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.52 Mil.

Black Bird Biotech (OTCPK:BBBT) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Black Bird Biotech's Interest Expense for the three months ended in Sep. 2023 was $-0.12 Mil. Its Operating Income for the three months ended in Sep. 2023 was $-0.01 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2023 was $0.00 Mil.

Black Bird Biotech's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Black Bird Biotech did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Black Bird Biotech (Black Bird Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Black Bird Biotech Inc (OTCPK:BBBT) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

11961 Hilltop Road, Suite 22, Argyle, TX, USA, 76226

Website

https://www.blackbirdpotentials.com

Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.

Executives

Jeffrey A Collins	director, 10 percent owner, officer: President	302 WASHINGTON ST., #513, SAN DIEGO CA 92103
Robert Edward Shea	director, 10 percent owner, officer: President, CEO, CFO, CAO	40 WARREN STREET, 3RD FLOOR, CHARLESTOWN MA 02129
John James Sutherland	director, 10 percent owner, officer: President, CEO, CFO & CAO	C/O SUITE 810 - 675 WEST HASTINGS STREET, VANCOUVER A1 V6B 1N2